Remove Clinical Development Remove Nurses Remove Pharmacy
article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

Oren Cohen, MD, FIDSA CMO & President of Clinical Pharmacology Fortrea Fortrea is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, market access solutions and other enabling services. They are unique and require specific expertise.” FIH studies involve a lot of risk.

article thumbnail

Assessing physician practices and expectations in the post-COVID era

pharmaphorum

Fewer patients coming in and out of an infusion centre may help infusion nurses and other staff to also reduce their potential exposure to COVID-19. These data cover about 30% of US pharmacy claims and about 50% of US medical claims for these conditions. Overview of patient claims data. Impact on patients.

Pharmacy 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

Senior Vice President and Head of Global Clinical Development at Regeneron and lead author of the publication. patients under an Emergency Use Authorization, and we also continue a robust clinical development program.” “The investigational cocktail is now available to indicated high-risk U.S.

article thumbnail

Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

The Pharma Data

Senior Vice President and Head of Global Clinical Development at Regeneron. Use in Specific Populations : Pregnancy: There is currently limited clinical experience in the use of casirivimab and imdevimab injection in COVID-19 patients who are pregnant.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

That said, the percentage of all COVID-19 deaths that occurred in nursing homes, standing at 81 percent, is the highest in the world followed by Spain at 66 percent. Yale hospital administrators bought about 1,200 reusable silicone masks and started distributing them to local doctors, nurses and respiratory therapists.

Vaccine 92